KITS, MOLECULAR DIAGNOSTICS
| Local Distributor |
Manufacturer |
Model Number (if applicable) |
Specifications |
BIO-STRATEGY LIMITED
|
NANOSTRING TECHNOLOGIES
|
| Prosigna™ Breast Cancer Prognostic Gene Signature Assay |
The Prosigna™ Breast Cancer Prognostic Gene Signature Assay is an in vitro diagnostic assay which uses the gene expression profile of cells found in breast cancer tissue to assess a patient’s risk of distant recurrence. The assay measures the gene expression profile using RNA extracted from Formalin-Fixed, Paraffin-Embedded (FFPE) breast tumor tissue. The gene expression data are weighted together with clinical variables to generate both a subtype (luminal A, luminal B, HER2-enriched, or basal-like) and a score indicative of the probability of distant recurrence of disease. The assay is performed on the NanoString nCounter® Analysis System using FFPE breast tumor tissue previously diagnosed as invasive breast carcinoma.
|
|
GLOBAL SCIENCE - a VWR company
|
AUSDIAGNOSTICS
|
| Easy-plex, High-Plex |
Automated system with kits for real-time multiplex PCR detection of pathogens for IVD diagnostics, veterinary and food applications. |
|
|
NGAIO DIAGNOSTICS
|
GREAT BASIN SCIENTIFIC
|
|
Multiplexes up to 64 distinct targets in a single assay for more answers. Rapid results in less than an hour depending on the target of interest. On-demand testing; no batching of tests that delays results. Fully automated with no more than two-to-three h |
|
NGAIO DIAGNOSTICS
|
INTRON BIOTECHNOLOGY
|
|
A range of kits for animal and plant diagnostics |